1α,25-Dihydroxy-16-Ene-23-Yne-26,27-Hexafluorocholecalciferol (Ro24-5531) Modulation of Insulin-Like Growth Factor-Binding Protein-3 and Induction of Differentiation and Growth Arrest in a Human Osteosarcoma Cell Line

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 93-99

  Velez Yanguas, Maria C ^a   Kalebic, Thea ^a   Maggi, Mario ^c   Kappel, Cynthia Chavez ^a   Letterio, John ^a   Uskokovic, Milan ^b   Helman, Lee J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

26,26,26,27,27,27 HEXAFLUORO 9,10 SECOCHOLESTA 5,7,10(19),16 TETRAENE 23 YNE 1,3,25 TRIOL; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BIGLYCAN; CALCITRIOL; CALCITRIOL DERIVATIVE; OSTEOCALCIN; PROTEIN KINASE; RO 24 5531; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG; BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN; SYNAPSIN II;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; DNA SYNTHESIS INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL LINE; DIFFERENTIATION; GROWTH DISORDER; MODULATION;

BONE DEVELOPMENT; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; OSTEOSARCOMA; RNA, MESSENGER;

EID: 0029670649     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.1.8550801     Document Type: Article

References (43)

1. Robey PG, Young MF, Kerr JM, et al. 1993 Comparative bone matrix biochemistry: normal and transformed cells. In: Novak JS, McMaster JH, eds. Frontiers of osteosarcoma research: interdisciplinary survey of clinical and research advances. Seattle: Hogrese and Huber; 205-214.
2. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. 1990 Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem. 38:1549-1563.
3. Kerner SA, Scott RA, Pike JW. 1989 Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA. 86:4455-4459.
4. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol. 123:401-409.
5. 3. J Biol Chem. 262:4165-4171.
6. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 98:391-398.
7. 3 in bones from fetal rats. Calcif Tissue Int. 35:177-82.
8. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep. 69:1399-1407.
9. 3. J Med Chem. 34:2452-2463.
10. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood. 78:75-82.
11. 3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res. 50:6857-6864.
12. Andreas DL, Birnbaum RS. 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 267:22467-22472.
13. Centrella M, McCarthy TL, Canalis E. 1990 Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone. Endocrinology. 126:39-44.
14. McCarthy TL, Centrella M, Canalis E. 1989 Regulatory effects of insulin-like growth factors-I and -II on bone collagen synthesis in rat calvarial cultures. Endocrinology. 124:301-309.
15. Kappel CC, Velez-Yanguas, MC, Hirschfeld S, Helman LJ. 1994 Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res. 54:2803-2807.
16. Brinkman A, Groffen C, Kortleve DJ, Geurts van Kessel A, Drop SLS. 1988 Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1). EMBO J. 7:2417-2423.
17. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD. 1990 Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. Mol Endocrinol. 4:1806-1814.
18. 281] insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor stimulated proliferation and collagen synthesis in fetal rat calvariae. J Biol Chem. 266:19469-19474.
19. 3. Endocrinology. 126:2088-2094.
20. 3 in regulation of function in clonal osteoblastic cells. Bone Miner. 5:335-345.
21. Hermans H, Billiau A, Cassiman JJ, Mulier JC, deSomer P. 1978 In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines. Oncology. 35:246-252.
22. Denizot F, Lang R. 1986 Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 89:271-277.
23. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechter MM, Israel MA. 1989 Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest. 84:829-839.
24. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
25. Fisher LW, Termine JD, Young MF. 1989 Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem. 264:4571-4576.
26. Fisher LW, McBride OW, Termine JD, Young MF. 1990 Human bone sialoprotein. J Biol Chem. 265:2347-2351.
27. Young MF, Kerr JM, Termine JD, et al. 1990 cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics. 7:491-502.
28. Shimasaki S, Ling N. 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res. 3:243-266.
29. 3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells. Biochim Biophys Acta. 1048:30-37.
30. Helman LJ, Thiele CJ, Linehan WM, Nelkin BD, Baylin SB, Israel MA. 1987 Molecular markers of neuroendocrine development and evidence of evironmental regulation. Proc Natl Acad Sci USA. 84:2336-2339.
31. Hossenlopp P, Seurin D, Segovia-Quinson BS, Hardouin S, Binoux M. 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 154:138-143.
32. 2 for control of mitosis in fission yeast. Nature. 292:558-560.
33. Munson PJ, Rodbard D. 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 107:220-239.
34. Stein GS, Lian JB, Owen TA. 1990 Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4:3111-3123.
35. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem. 267:8943-8949.
36. 3 and activity on human osteoblast-like cells in short-term cultures. Bone. 11:81-86.
37. Canalis E, Lian JB. 1988 Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone. 9:243-246.
38. Pollak MN, Polychronakos C, Richard M. 1990 Insulin-like growth factor I: a potent mitogen for human osteogenic sarcoma. J Natl Cancer Inst. 82:301-305.
39. Hock JM, Centrella M, Canalis E. 1988 Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology. 122:254-260.
40. Wood WI, Cachianes G, Henzel WJ, et al. 1988 Cloning and expression of the growth hormone-dependent insulin-like growth factor binding protein. Mol Endocrinol. 2:1176.
41. 3 stimulates the secretion of insulin-like growth factor binding protein 3 (IGFBP-3) by cultured human osteosarcoma cells. Endocrinology. 130:1071-1073.
42. Campbell PG, Novak JF. 1991 Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells. Cell Physiol. 149: 293-300,
43. Ernst M, Rodan GA. 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology. 127:807-814.